Hepatitis C

Top Story

Study confirms relevance of SVR endpoint for patients receiving HCV treatment

Study confirms relevance of SVR endpoint for patients receiving HCV treatment
February 28, 2020
In the Journals

DDIs affect around 40% of HCV patients taking DAAs

February 24, 2020
Drug-drug interactions, or DDIs, affect about 40% of patients with hepatitis C virus being treated with direct-acting antivirals, or DAAs, according to a study published…
In the Journals

90% of injection drug users miss opportunities for HIV or HCV testing

February 20, 2020
Using data from more than 840,000 health care encounters, researchers estimated that around 90% of people who inject drugs missed opportunities for HIV or hepatitis C…
In the Journals

Estimated global prevalence of pediatric HCV at more than 3 million

January 29, 2020
An analysis of peer-reviewed articles provided global prevalence estimates of hepatitis C virus in children, according to data from a modelling study. “Although we…
More Headlines »